Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06346340 · ClinicalTrials.gov registry record · Phase 4
A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy
A Phase 4 study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 4
- Development phase
- 97
- Enrollment target
NCT06346340 is a Phase 4 study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 97 participants.
The verdict
NCT06346340, a Phase 4 study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 97 participants
- Enrollment target
Study Summary
A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy
Interventions
- DRUG Miebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2024-04-30 |
| Est. Completion | 2025-02-24 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06346340
The ClinicalTrials.gov registry entry for NCT06346340 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Miebo is the first listed.
NCT06346340 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06346340 about?
NCT06346340 is a clinical study titled "A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy". A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/ Keratometry and Postoperative Refractive Accuracy
What is the current status of trial NCT06346340?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 97 participants. The study started on 2024-04-30. Estimated completion is 2025-02-24.
What interventions are being tested in trial NCT06346340?
The interventions under investigation include: Miebo (DRUG).
Who is sponsoring clinical trial NCT06346340?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.